CareDx, Inc. (CDNA) stock
CDNANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 12/3027% above fair value
$74.44−0.12 (-0.16%)
Close on Nov 18, 2026Market cap $3.91BP/E 31.1Yield –
CareDx gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
CareDx's gross profit for the twelve months ending Jun 30, 2020 was $98.19M, up 59.7% year over year. For fiscal 2019 it was $81.61M, up 87.3% from the year before. The highest annual figure on record is $81.61M in fiscal 2019.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $81.61M | +87.3% |
| FY2018 | Dec 31, 2018 | $43.58M | +61.7% |
| FY2017 | Dec 31, 2017 | $26.95M | -11.3% |
| FY2016 | Dec 31, 2016 | $30.39M | +8.0% |
| FY2015 | Dec 31, 2015 | $28.14M | +3.1% |
| FY2014 | Dec 31, 2014 | $27.31M | +109.7% |
| FY2013 | Dec 31, 2013 | $13.02M | +4.0% |
| FY2012 | Dec 31, 2012 | $12.52M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | $26.78M | +34.3% |
| Q1 FY2020 | Mar 31, 2020 | $25.99M | +59.9% |
| Q4 FY2019 | Dec 31, 2019 | $23.11M | +77.7% |
| Q3 FY2019 | Sep 30, 2019 | $22.32M | +81.5% |
| Q2 FY2019 | Jun 30, 2019 | $19.94M | +87.8% |
| Q1 FY2019 | Mar 31, 2019 | $16.25M | +37.9% |
| Q4 FY2018 | Dec 31, 2018 | $13.00M | – |
| Q3 FY2018 | Sep 30, 2018 | $12.30M | +21.3% |
| Q2 FY2018 | Jun 30, 2018 | $10.62M | +7.6% |
| Q1 FY2018 | Mar 31, 2018 | $11.78M | +27.3% |
| Q4 FY2017 | Dec 31, 2017 | -$2.31M | -132.9% |
| Q3 FY2017 | Sep 30, 2017 | $10.14M | – |
| Q2 FY2017 | Jun 30, 2017 | $9.87M | – |
| Q1 FY2017 | Mar 31, 2017 | $9.26M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.03M | – |
See a number that looks wrong?